What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies?

Yvonne Y. Chen, Wendell Lim, Megan Levings, Bruce Blazar, Giedre Krenciute, Wilson Wong, Manfred Lehner

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)212-214
Number of pages3
JournalCell Systems
Issue number3
StatePublished - Sep 23 2020

Cite this